Genome Mining and Metabolomics Uncover a Rare D-Capreomycidine Containing Natural Product and Its Biosynthetic Gene Cluster

James H. Tryon,Jennifer C. Rote,Li Chen,Matthew T. Robey,Marvin M. Vega,Wan Cheng Phua,William W. Metcalf,Kou-San Ju,Neil L. Kelleher,Regan J. Thomson
DOI: https://doi.org/10.1021/acschembio.0c00663
IF: 4.634
2020-01-01
ACS Chemical Biology
Abstract:We report the metabolomics-driven genome mining of a new cyclic-guanidino incorporating non-ribosomal peptide synthetase (NRPS) gene cluster and full structure elucidation of its associated hexapeptide product, faulknamycin. Structural studies unveiled that this natural product contained the previously unknown (R,S)-stereoisomer of capreomycidine, d-capreomycidine. Furthermore, heterologous expression of the identified gene cluster successfully reproduces faulknamycin production without an observed homologue of VioD, the pyridoxal phosphate (PLP)-dependent enzyme found in all previous l-capreomycidine biosynthesis. An alternative NRPS-dependent pathway for d-capreomycidine biosynthesis is proposed.
What problem does this paper attempt to address?